ResMed Inc.
RMD
$251.69
$3.111.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.93% | 10.68% | 6.54% | -2.75% | 43.91% |
| Total Depreciation and Amortization | -7.78% | 4.76% | -1.54% | 0.22% | 3.11% |
| Total Amortization of Deferred Charges | -2.22% | -0.87% | -4.52% | 0.12% | -2.51% |
| Total Other Non-Cash Items | 27.98% | 15.71% | -44.79% | 491.88% | -88.78% |
| Change in Net Operating Assets | 215.13% | -93.43% | -203.98% | 39.96% | 193.68% |
| Cash from Operations | 87.50% | -5.20% | -26.03% | 9.47% | 47.35% |
| Capital Expenditure | -0.74% | -15.72% | 28.30% | -17.41% | 9.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -539.72% | 58.97% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.53% | -176.94% | 1,135.01% | 78.26% | 13.64% |
| Cash from Investing | 13.37% | -1,809.79% | 104.61% | -40.29% | 19.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 83.33% | 90.00% | -36.36% | -69.23% |
| Issuance of Common Stock | -66.43% | 220.61% | -69.73% | 466.13% | -74.94% |
| Repurchase of Common Stock | 17.80% | -82.01% | 0.06% | -0.22% | 12.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.01% | 0.25% | -10.40% | -0.09% | 0.26% |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 2.35% | 2.14% | 61.67% | -17.08% | -40.57% |
| Foreign Exchange rate Adjustments | 127.64% | -360.18% | 8,483.72% | 102.43% | -163.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 329.75% | -49.16% | 41,585.14% | -98.37% | 2,311.77% |